文献
J-GLOBAL ID:202202279476820791
整理番号:22A1046694
再発卵巣癌におけるオラパリブ単独療法対医師選択化学療法の無作為化CLIO/BGOG-ov10試験【JST・京大機械翻訳】
Randomized CLIO/BGOG-ov10 trial of olaparib monotherapy versus physician’s choice chemotherapy in relapsed ovarian cancer
著者 (30件):
Vanderstichele Adriaan
(Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium)
,
Vanderstichele Adriaan
(Laboratory of Gynaecological Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium)
,
Loverix Liselore
(Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium)
,
Loverix Liselore
(Laboratory of Gynaecological Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium)
,
Busschaert Pieter
(Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium)
,
Busschaert Pieter
(Laboratory of Gynaecological Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium)
,
Busschaert Pieter
(Laboratory for Translational Genetics, Department of Oncology, KU Leuven, Leuven, Belgium)
,
Busschaert Pieter
(Center for Cancer Biology, VIB, Leuven, Belgium)
,
Van Nieuwenhuysen Els
(Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium)
,
Van Nieuwenhuysen Els
(Laboratory of Gynaecological Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium)
,
Han Sileny N.
(Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium)
,
Han Sileny N.
(Laboratory of Gynaecological Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium)
,
Concin Nicole
(Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium)
,
Concin Nicole
(Laboratory of Gynaecological Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium)
,
Callewaert Tiene
(Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium)
,
Callewaert Tiene
(Laboratory of Gynaecological Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium)
,
Olbrecht Siel
(Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium)
,
Olbrecht Siel
(Laboratory of Gynaecological Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium)
,
Salihi Rawand
(Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium)
,
Salihi Rawand
(Laboratory of Gynaecological Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium)
,
Berteloot Patrick
(Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium)
,
Berteloot Patrick
(Laboratory of Gynaecological Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium)
,
Neven Patrick
(Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium)
,
Neven Patrick
(Laboratory of Gynaecological Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium)
,
Lambrechts Diether
(Laboratory for Translational Genetics, Department of Oncology, KU Leuven, Leuven, Belgium)
,
Lambrechts Diether
(Center for Cancer Biology, VIB, Leuven, Belgium)
,
Van Gorp Toon
(Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium)
,
Van Gorp Toon
(Laboratory of Gynaecological Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium)
,
Vergote Ignace
(Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium)
,
Vergote Ignace
(Laboratory of Gynaecological Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium)
資料名:
Gynecologic Oncology
(Gynecologic Oncology)
巻:
165
号:
1
ページ:
14-22
発行年:
2022年
JST資料番号:
E0561C
ISSN:
0090-8258
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)